Literature DB >> 7835810

Management of the adnexal mass.

J P Curtin1.   

Abstract

The methods for preoperative diagnosis and evaluation of the woman with a suspected ovarian neoplasm have evolved significantly with little or no impact on the surgical treatment, which remains removal of the abnormal ovary. Although most adnexal masses are benign, the primary goal of the diagnostic evaluation is the exclusion of malignancy. A complete history, physical examination, and ultrasonic imaging are vital in evaluating a suspected ovarian mass. In postmenopausal women, serum CA-125 determinations further improve sensitivity and specificity. Once the presence of an ovarian mass is established, the crucial decision is whether to observe the patient or proceed with surgical removal. If surgical removal is indicated, the proper procedure is important for staging and initiation of effective therapy. While many surgeons are now using the less invasive laparoscopic approach, the standard of care continues to be a laparotomy with either an ovarian cystectomy or oophorectomy. Future clinical research in the management of adnexal masses should focus on decreasing the number of patients undergoing a surgical procedure, and in patients who require surgery, further evaluation of laparoscopy as a safe, cost-effective means of treatment. Improved imaging techniques may allow for nonoperative management of probably benign ovarian neoplasms.

Entities:  

Mesh:

Year:  1994        PMID: 7835810     DOI: 10.1006/gyno.1994.1340

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  29 in total

1.  Characterization of Adnexal Masses Using Contrast-Enhanced Subharmonic Imaging: A Pilot Study.

Authors:  Lauren J Delaney; Priscilla Machado; Mehnoosh Torkzaban; Andrej Lyshchik; Corinne E Wessner; Christine Kim; Norman Rosenblum; Scott Richard; Kirk Wallace; Flemming Forsberg
Journal:  J Ultrasound Med       Date:  2019-11-26       Impact factor: 2.153

2.  MR imaging compared with intraoperative frozen-section examination for the diagnosis of adnexal tumors; correlation with final histology.

Authors:  Marc Bazot; Jinane Nassar-Slaba; Isabelle Thomassin-Naggara; Annie Cortez; Serge Uzan; Emile Daraï
Journal:  Eur Radiol       Date:  2006-03-18       Impact factor: 5.315

3.  Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses.

Authors:  Isabelle Thomassin-Naggara; Emile Daraï; Charles A Cuenod; Laure Fournier; Irwin Toussaint; Claude Marsault; Marc Bazot
Journal:  Eur Radiol       Date:  2009-02-13       Impact factor: 5.315

4.  Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass.

Authors:  Richard G Moore; Moune Jabre-Raughley; Amy K Brown; Katina M Robison; M Craig Miller; W Jeffery Allard; Robert J Kurman; Robert C Bast; Steven J Skates
Journal:  Am J Obstet Gynecol       Date:  2010-05-14       Impact factor: 8.661

Review 5.  The role of biomarkers in the management of epithelial ovarian cancer.

Authors:  Wei-Lei Yang; Zhen Lu; Robert C Bast
Journal:  Expert Rev Mol Diagn       Date:  2017-05-15       Impact factor: 5.225

Review 6.  Unexpected gynecologic findings during abdominal surgery.

Authors:  Casey A Boyd; Taylor S Riall
Journal:  Curr Probl Surg       Date:  2012-04       Impact factor: 1.909

7.  Risk of Malignant Ovarian Cancer Based on Ultrasonography Findings in a Large Unselected Population.

Authors:  Rebecca Smith-Bindman; Liina Poder; Eric Johnson; Diana L Miglioretti
Journal:  JAMA Intern Med       Date:  2019-01-01       Impact factor: 21.873

8.  A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.

Authors:  Richard G Moore; D Scott McMeekin; Amy K Brown; Paul DiSilvestro; M Craig Miller; W Jeffrey Allard; Walter Gajewski; Robert Kurman; Robert C Bast; Steven J Skates
Journal:  Gynecol Oncol       Date:  2008-10-12       Impact factor: 5.482

Review 9.  Pelvic incidentalomas.

Authors:  R M Gore; G M Newmark; K H Thakrar; U K Mehta; J W Berlin
Journal:  Cancer Imaging       Date:  2010-10-04       Impact factor: 3.909

Review 10.  Current state of biomarker development for clinical application in epithelial ovarian cancer.

Authors:  Richard G Moore; Shannon MacLaughlan; Robert C Bast
Journal:  Gynecol Oncol       Date:  2009-10-31       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.